Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn's Disease: Apropos of a Case

Mesalazine- (5-aminosalicylic acid-) containing products are a well-known treatment for inflammatory bowel disease, often as first line. Myocarditis is recognized as a very rare possible side effect of this drug treatment. We present a case of mesalazine-induced myopericarditis that was successfully...

Descripción completa

Detalles Bibliográficos
Autores principales: Sorleto, Michele, Dürrwald, Stefanie, Wiemer, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523686/
https://www.ncbi.nlm.nih.gov/pubmed/26266055
http://dx.doi.org/10.1155/2015/728310
_version_ 1782384090059636736
author Sorleto, Michele
Dürrwald, Stefanie
Wiemer, Marcus
author_facet Sorleto, Michele
Dürrwald, Stefanie
Wiemer, Marcus
author_sort Sorleto, Michele
collection PubMed
description Mesalazine- (5-aminosalicylic acid-) containing products are a well-known treatment for inflammatory bowel disease, often as first line. Myocarditis is recognized as a very rare possible side effect of this drug treatment. We present a case of mesalazine-induced myopericarditis that was successfully improved by immediate cessation of the medication.
format Online
Article
Text
id pubmed-4523686
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-45236862015-08-11 Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn's Disease: Apropos of a Case Sorleto, Michele Dürrwald, Stefanie Wiemer, Marcus Case Rep Cardiol Case Report Mesalazine- (5-aminosalicylic acid-) containing products are a well-known treatment for inflammatory bowel disease, often as first line. Myocarditis is recognized as a very rare possible side effect of this drug treatment. We present a case of mesalazine-induced myopericarditis that was successfully improved by immediate cessation of the medication. Hindawi Publishing Corporation 2015 2015-07-21 /pmc/articles/PMC4523686/ /pubmed/26266055 http://dx.doi.org/10.1155/2015/728310 Text en Copyright © 2015 Michele Sorleto et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Sorleto, Michele
Dürrwald, Stefanie
Wiemer, Marcus
Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn's Disease: Apropos of a Case
title Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn's Disease: Apropos of a Case
title_full Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn's Disease: Apropos of a Case
title_fullStr Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn's Disease: Apropos of a Case
title_full_unstemmed Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn's Disease: Apropos of a Case
title_short Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn's Disease: Apropos of a Case
title_sort mesalazine-induced myopericarditis in a patient with a recent diagnosis of crohn's disease: apropos of a case
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523686/
https://www.ncbi.nlm.nih.gov/pubmed/26266055
http://dx.doi.org/10.1155/2015/728310
work_keys_str_mv AT sorletomichele mesalazineinducedmyopericarditisinapatientwitharecentdiagnosisofcrohnsdiseaseaproposofacase
AT durrwaldstefanie mesalazineinducedmyopericarditisinapatientwitharecentdiagnosisofcrohnsdiseaseaproposofacase
AT wiemermarcus mesalazineinducedmyopericarditisinapatientwitharecentdiagnosisofcrohnsdiseaseaproposofacase

Ejemplares similares